CoChat

Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids

Open access
Vergara, M. Natalia, Flores-Bellver, Miguel, Aparicio-Domingo, Silvia, McNally, Minda, Wahlin, Karl J., Saxena, Meera T., Mumm, Jeff S., Canto-Soler, M. Valeria · 2017 · Development
Cited by 77

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The advent of stem cell-derived retinal organoids has brought forth unprecedented opportunities for developmental and physiological studies, while presenting new therapeutic promise for retinal degenerative diseases. From a translational perspective, organoid systems provide exciting new prospects for drug discovery, offering the possibility to perform compound screening in a three-dimensional (3D) human tissue context that resembles the native histoarchitecture and to some extent recapitulates cellular interactions. However, inherent variability issues and a general lack of robust quantitative technologies for analyzing organoids on a large scale pose severe limitations for their use in translational applications. To address this need, we have developed a screening platform that enables accurate quantification of fluorescent reporters in complex human iPSC-derived retinal organoids. This platform incorporates a fluorescence microplate reader that allows xyz-dimensional detection and fine-tuned wavelength selection. We have established optimal parameters for fluorescent reporter signal detection, devised methods to compensate for organoid size variability, evaluated performance and sensitivity parameters, and validated this technology for functional applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/dev.146290

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • How to improve R&D productivity: the pharmaceutical industry's grand challenge

    Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 2×

    “…compound identification, but when taken to clinical trials 90% of these compounds fail to progress through phase I, resulting in billions of dollars in economic losses and delays in the development of much-needed therapeutic agents (Hynds and Giangreco, 2013; Paul et al., 2010; Ranga et al., 2014).”
    Background
  • Organoids as an in vitro model of human development and disease

    Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · cited 6×

    “…cellbased models and technologies, and for good reason, since these systems have opened up numerous opportunities for basic research and clinical applications (Canto-Soler et al., 2016; Fatehullah et al., 2016; Hynds and Giangreco, 2013; Wright et al., 2014; Xinaris et al., 2015; Yin et al., 2016).”
    BackgroundInfluential
  • Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs

    Zhong, X., Gutierrez, C., Xue, T., Hampton, C., Vergara, M. N., Cao, L.-H., Peters, A., Park, T. S., Zambidis, E. T., Meyer, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5047 · Cited by 970 · cited 9×

    “…at various differentiation stages were fixed in 4% paraformaldehyde for 10 min and labeled using rabbit antiOtx2 antibody (Millipore, AB9566; Zhong et al., 2014) or goat anti-Brn3b (Pou4f2) antibody (Santa Cruz Biotechnologies, SC-6026x), followed by incubation with goat anti-rabbit Alexa…”
    BackgroundMethodResultInfluentialSelf-citation
  • Oxidative damage-induced inflammation initiates age-related macular degeneration

    Hollyfield, J. G., Bonilha, V. L., Rayborn, M. E., Yang, X., Shadrach, K. G., Lu, L., Ufret, R. L., Salomon, R. G., & Perez, V. L. (2008) · Nature Medicine · doi:10.1038/nm1709 · Cited by 710 · cited 1×

    “…is at the basis of the pathophysiology of many chronic diseases, including those affecting the retina (Athanasiou et al., 2013; Cano et al., 2010; Hollyfield et al., 2008; Jarrett and Boulton, 2012; Kowluru and Chan, 2007; Masuda et al., 2017; Nita and Grzybowski, 2016; Nishimura et al., 2017;…”
    Background
  • Drug discovery through stem cell-based organoid models

    Ranga, A., Gjorevski, N., & Lutolf, M. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.006 · Cited by 195 · cited 4×

    “In this scenario, human stem cell-derived organoids have the potential to bridge the gap between primary compound screening, costly animal studies, and human trials, as they provide a more physiologically relevant, human-based context, while allowing the necessary flexibility and level of control of an in vitro system…”
    BackgroundInfluential

Show all 5 references

Cited by

See all 77

Metadata

Authors
Vergara, M. N., Flores-Bellver, M., Aparicio-Domingo, S., McNally, M., Wahlin, K. J., Saxena, M. T., Mumm, J. S., & Canto-Soler, M. V.
Venue
Development
Published
2017-10-15
Volume
144
Issue
20
Pages
3698-3705
ISSN
  • 0950-1991 (ISSN-L)
  • 1477-9129
OpenAlex
W2751345613
Cited by
77
References
5
FWCI
2.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids. https://app.cochat.ai/papers/10.1242/dev.146290
The paper
Vergara, M. N., Flores-Bellver, M., Aparicio-Domingo, S., McNally, M., Wahlin, K. J., Saxena, M. T., Mumm, J. S., & Canto-Soler, M. V. (2017). Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids. Development. https://doi.org/10.1242/dev.146290

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.